TNGX
Tango Therapeutics (TNGX) Earnings
Review Tango Therapeutics (TNGX) earnings with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Annual EPS
- -0.87
- Trailing EPS
- -0.85
- Annual revenue
- $62.38M
- Trailing revenue
- $53.81M
- Next earnings date
- 2026-08-11
- Earnings data source
- MarketBeat historical revenue consensus + Finnhub earnings
Tango Therapeutics (TNGX) Earnings research
The TNGX earnings page organizes the available earnings-per-share and revenue context for Tango Therapeutics. Earnings trends are more informative when actual results are compared with prior periods, market expectations and management guidance.
Quarterly surprises can move a share price, but their long-term importance depends on margins, cash flow and the durability of demand. Continue to the financials and valuation pages for a broader view.